Misoone (Misoprostol)

Misoprostol activates prostaglandin E1 (EP) receptors. In the stomach, this stimulates mucus and bicarbonate secretion, protecting the lining. In the uterus, EP‑receptor activation raises intracellular calcium, causing smooth‑muscle contraction that leads to cervical softening and uterine activity.

The prescribed dose of Misoone is determined by the treating clinician based on the specific indication, patient characteristics, and local guidelines. No fixed regimen is provided here; dosing must follow the prescriber’s instructions.

Safety of misoprostol during pregnancy and lactation is not fully established. It is used intentionally for pregnancy termination or labor induction under strict medical supervision, but it is contraindicated for other uses in pregnant women. Breastfeeding decisions should be made by a healthcare professional.

To order Misoone, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Misoone (misoprostol) is a synthetic prostaglandin E1 analog, whereas the main alternative for cervical ripening and labor induction is dinoprostone, a prostaglandin E2 analog. Misoprostol is generally less expensive, has a longer shelf‑life, and can be administered orally, but it may have a higher risk of uterine hyperstimulation compared with dinoprostone.

Misoone should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or direct sunlight.

Misoone is taken orally, usually with a full glass of water. The exact timing relative to meals or other medications depends on the indication and the prescriber’s instructions. Swallow the tablet whole; do not crush or chew unless specifically directed by a healthcare professional.

Serious risks include severe uterine bleeding, uterine rupture, and allergic reactions such as rash, swelling or difficulty breathing. Patients should seek immediate medical attention if they experience heavy vaginal bleeding, sudden severe abdominal pain, or signs of anaphylaxis.

Misoone should not be used by individuals with known hypersensitivity to misoprostol or other prostaglandin analogs, those with active peptic ulcer disease, or patients for whom uterine contraction is contraindicated. It is also avoided in women who are not intended to become pregnant when used for obstetric purposes.